Cefprozil

Product NDC
65862-100
11-digit product format
658620100
Labeler code
65862
Product ID
65862-100_3c7c4d11-bbf8-4861-add8-0772d41daef5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cefprozil
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA065381
Marketing category
ANDA
Marketing start
2007-01-30
Substance
CEFPROZIL
Active strength
250 mg/5mL
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A065381-001CEFPROZILCEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30
A065381-002CEFPROZILCEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A065381-001AB
A065381-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30caaa826d4ba7…
2026-08-18 06:07:402026-07A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-3031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-306a471c1ec25d…
2025-08-23 18:47 UTC2025-08A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-3003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-302680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-305bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30d06236e962d9…
2024-10-29 15:01 UTC2024-10A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-3079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-301e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-308072bd15b7f6…
2024-05-31 18:47 UTC2024-05A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-305c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-305d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-305d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-304b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-304b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-3074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A065381-001CEFPROZIL125MG/5MLFOR SUSPENSION / ORALAB2007-01-30bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A065381-002CEFPROZIL250MG/5MLFOR SUSPENSION / ORALAB2007-01-30bb7c543d1eb4…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A065381-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A065381-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A065381-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A065381-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065381-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065381-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A065381-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A065381-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065381-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065381-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065381-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065381-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065381-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065381-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065381-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065381-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065381-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065381-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065381-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065381-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A065381-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A065381-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065381-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065381-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065381-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065381-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065381-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065381-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A065381-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A065381-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065381-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065381-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A065381-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A065381-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A065381-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A065381-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A065381-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A065381-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A065381-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A065381-002AB1bb7c543d1eb4…

Additional Listing Data#

Finished product
Yes
Brand name base
Cefprozil
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEFPROZIL250 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4W0459ZA4VInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
309080Internal RxNorm lookup
309081Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
97675251-70b8-43bc-93ea-f9ef6bb8cb68Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
228ef569-e7f1-4dcf-b820-c09522f86f2eProduct name120250129
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65862-100-01Cefprozil100 mL in 1 BOTTLEPOWDER, FOR SUSPENSION10012
65862-100-50Cefprozil50 mL in 1 BOTTLEPOWDER, FOR SUSPENSION5012
65862-100-75Cefprozil75 mL in 1 BOTTLEPOWDER, FOR SUSPENSION7512

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
65862-100-01ML - Milliliter65862-1004bfdee22-b787-4ab1-b3cb-af75aed568d912012-07-24
65862-100-75ML - Milliliter65862-1006adcabdc-c5f5-474b-8c85-39f5e201dee812012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CEFPROZILACTIVE INGREDIENT4W0459ZA4VCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
CEFPROZIL ANHYDROUSACTIVE MOIETY1M698F4H4ECEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1CEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
CARBOXYMETHYLCELLULOSE SODIUMINACTIVE INGREDIENTK679OBS311CEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1OCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
FD&C RED NO. 3INACTIVE INGREDIENTPN2ZH5LOQYCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
GLYCINEINACTIVE INGREDIENTTE7660XO1CCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XCEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6
SUCROSEINACTIVE INGREDIENTC151H8M554CEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65862-100CEFPROZIL POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED]12Current NDC, Legacy NDC, 3 package rows20240521_97675251-70b8-43bc-93ea-f9ef6bb8cb68.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefprozilCEFPROZILNorthStar Rx LLC8e3943b5-8c30-4c81-bcfa-aeaaa1d75fb42026-07-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065381
application number: ANDA065381
CefprozilCEFPROZILRising Pharma Holdings, Inc.d7fac9cc-30e1-4762-a01b-04f1bd3b2a562024-05-18Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065381
application number: ANDA065381
CefprozilCEFPROZILAurobindo Pharma Limited97675251-70b8-43bc-93ea-f9ef6bb8cb682024-05-18Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065381
application number: ANDA065381
ndc (product): 65862-100
CefprozilCEFPROZILA-S Medication Solutions8e292a8d-9fd6-45fb-8fb5-d8cb25a4b46d2024-01-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065381
application number: ANDA065381

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
309080cefprozil 125 MG in 5 mL Oral SuspensionPSN97675251-70b8-43bc-93ea-f9ef6bb8cb6812
309081cefprozil 250 MG in 5 mL Oral SuspensionPSN97675251-70b8-43bc-93ea-f9ef6bb8cb6812
309080cefprozil 25 MG/ML Oral SuspensionSCD97675251-70b8-43bc-93ea-f9ef6bb8cb6812
309081cefprozil 50 MG/ML Oral SuspensionSCD97675251-70b8-43bc-93ea-f9ef6bb8cb6812
309080cefprozil 125 MG per 5 ML Oral SuspensionSY97675251-70b8-43bc-93ea-f9ef6bb8cb6812
309081cefprozil 250 MG per 5 ML Oral SuspensionSY97675251-70b8-43bc-93ea-f9ef6bb8cb6812

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
65862-100-0165862010001100 mL in 1 BOTTLE (65862-100-01) 100 ml2007-01-300000-00-00NoNoCurrent
65862-100-506586201005050 mL in 1 BOTTLE (65862-100-50) 50 ml2007-01-300000-00-00NoNoCurrent
65862-100-756586201007575 mL in 1 BOTTLE (65862-100-75) 75 ml2007-01-300000-00-00NoNoCurrent